Myomo (MYO) Net Cash Flow (QoQ) (2016 - 2025)
Myomo (MYO) Net Cash Flow (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.25 Bn | 6.27 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.32 Bn | 43.65 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.18 Bn | 1.98 Bn |
| 7 | Dexcom | 28.46 Bn | 27.34 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 69.96% |
| Jun 30, 2025 | -21.98% |
| Mar 31, 2025 | -125.92% |
| Dec 31, 2024 | 1,471.64% |
| Sep 30, 2024 | 172.83% |
| Jun 30, 2024 | 129.08% |
| Mar 31, 2024 | -2,228.10% |
| Dec 31, 2023 | -106.66% |
| Sep 30, 2023 | 128.23% |
| Jun 30, 2023 | -183.30% |
| Mar 31, 2023 | 287.03% |
| Dec 31, 2022 | 25.45% |
| Sep 30, 2022 | -3.84% |
| Jun 30, 2022 | -5.03% |
| Mar 31, 2022 | -188.43% |
| Dec 31, 2021 | 353.58% |
| Sep 30, 2021 | 68.13% |
| Jun 30, 2021 | -170.14% |
| Mar 31, 2021 | 554.26% |
| Dec 31, 2020 | -144.25% |